The SpaceX IPO is just days away, and it won't be long before it gets added to many index funds, giving investors exposure to ...
Incyte will acquire Vega Therapeutics for up to $2B, adding late-stage VWD candidate VGA039 and expanding its hematology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results